Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PALIVIZUMAB vs PANOBINOSTAT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

PALIVIZUMAB vs PANOBINOSTAT: Safety Overview

Metric PALIVIZUMAB PANOBINOSTAT
Total FAERS Reports 11,419 1,820
Deaths Reported 1,248 517
Death Rate 10.9% 28.4%
Hospitalizations 6,461 623
Average Patient Age 0.8 yrs 61.8 yrs
% Female Patients 42.2% 49.7%
FDA Approval Date N/A Feb 23, 2015
Manufacturer Swedish Orphan Biovitrum AB (publ) N/A
Route INTRAMUSCULAR N/A
Marketing Status Prescription Discontinued